메뉴 건너뛰기




Volumn 30, Issue 6, 2005, Pages 458-466

Metabolic syndrome and hyperlipidemia in HIV-positive patients;Metabolisches syndrom und hyperlipidämie bei HIV-positiven patienten

Author keywords

HIV infection; Insulin resistance; Metabolic syndrome

Indexed keywords

ABACAVIR; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; ATORVASTATIN; BEZAFIBRATE; CYTOCHROME P450 3A4; EFAVIRENZ; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; LOW DENSITY LIPOPROTEIN; METFORMIN; MEVINOLIN; NEVIRAPINE; PIOGLITAZONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRAVASTATIN; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ROSIGLITAZONE; SAQUINAVIR; SIMVASTATIN; STAVUDINE; TENOFOVIR DISOPROXIL; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG; ZIDOVUDINE;

EID: 25444508420     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2722-5     Document Type: Article
Times cited : (3)

References (57)
  • 1
    • 0037323424 scopus 로고    scopus 로고
    • Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly acitve antiretroviral therapy
    • Addy CL, Gavrila A, Tsiodras S, et al. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly acitve antiretroviral therapy. J Clin Endocrinol Metab 2003;88:627-36.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 627-636
    • Addy, C.L.1    Gavrila, A.2    Tsiodras, S.3
  • 2
    • 0842303102 scopus 로고    scopus 로고
    • Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults
    • Badiou S, Merle De Boever C, Dupuy AM, et al. Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults. Atherosclerosis 2004;172:273-9.
    • (2004) Atherosclerosis , vol.172 , pp. 273-279
    • Badiou, S.1    Merle De Boever, C.2    Dupuy, A.M.3
  • 3
    • 0037131318 scopus 로고    scopus 로고
    • Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia
    • Barrios A, Blanco F, Garcia-Benayas T, et al. Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia. AIDS 2002;16:2079-81.
    • (2002) AIDS , vol.16 , pp. 2079-2081
    • Barrios, A.1    Blanco, F.2    Garcia-Benayas, T.3
  • 4
    • 0037161026 scopus 로고    scopus 로고
    • Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance
    • Bastard JP, Caron M, Vidal H, et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 2002;359:1026-31.
    • (2002) Lancet , vol.359 , pp. 1026-1031
    • Bastard, J.P.1    Caron, M.2    Vidal, H.3
  • 5
    • 0032797624 scopus 로고    scopus 로고
    • Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
    • Behrens G, Dejam A, Schmidt H, et al. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 1999;13:F63-70.
    • (1999) AIDS , vol.13
    • Behrens, G.1    Dejam, A.2    Schmidt, H.3
  • 6
    • 0033933880 scopus 로고    scopus 로고
    • Lipodystrophy syndrome in HIV infection: What is it, what causes it and how can it be managed?
    • Behrens GM, Stoll M, Schmidt RE. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? Drug Saf 2000;23:57-76.
    • (2000) Drug Saf , vol.23 , pp. 57-76
    • Behrens, G.M.1    Stoll, M.2    Schmidt, R.E.3
  • 7
    • 17244372383 scopus 로고    scopus 로고
    • Cardiovascular risk and body-fat abnormalities in HIV-infected adults
    • Behrens GMN. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005;352:1721-2.
    • (2005) N Engl J Med , vol.352 , pp. 1721-1722
    • Behrens, G.M.N.1
  • 8
    • 0036840098 scopus 로고    scopus 로고
    • Impaired glucose phosphorylation and transport in skeletal muscle causes insulin resistance in HIV-1 infected patients with lipodystrophy
    • Behrens GMN, Boerner AR, Weber K, et al. Impaired glucose phosphorylation and transport in skeletal muscle causes insulin resistance in HIV-1 infected patients with lipodystrophy. J Clin Invest 2002;110:1319-27.
    • (2002) J Clin Invest , vol.110 , pp. 1319-1327
    • Behrens, G.M.N.1    Boerner, A.R.2    Weber, K.3
  • 9
    • 0346992125 scopus 로고    scopus 로고
    • Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: Results from a Norwegian study of 721 patients
    • Bergersen BM, Sandvik L, Dunlop O, et al. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis 2003;22:731-6.
    • (2003) Eur J Clin Microbiol Infect Dis , vol.22 , pp. 731-736
    • Bergersen, B.M.1    Sandvik, L.2    Dunlop, O.3
  • 10
    • 0037456351 scopus 로고    scopus 로고
    • Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection
    • Bozzette SA, Ake CF, Tam HK, et al. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003;348:702-10.
    • (2003) N Engl J Med , vol.348 , pp. 702-710
    • Bozzette, S.A.1    Ake, C.F.2    Tam, H.K.3
  • 11
    • 0033604038 scopus 로고    scopus 로고
    • Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
    • Brinkman K, Smeitink JA, Romijn JA, et al. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 1999;354:1112-5.
    • (1999) Lancet , vol.354 , pp. 1112-1115
    • Brinkman, K.1    Smeitink, J.A.2    Romijn, J.A.3
  • 12
    • 0038301516 scopus 로고    scopus 로고
    • Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
    • Calza L, Manfredi R, Chiodo F. Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART. AIDS 2003;17:851-9.
    • (2003) AIDS , vol.17 , pp. 851-859
    • Calza, L.1    Manfredi, R.2    Chiodo, F.3
  • 13
    • 0034987343 scopus 로고    scopus 로고
    • The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance
    • Caron M, Auclair M, Vigouroux C, et al. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 2001;50:1378-88.
    • (2001) Diabetes , vol.50 , pp. 1378-1388
    • Caron, M.1    Auclair, M.2    Vigouroux, C.3
  • 14
    • 0037333717 scopus 로고    scopus 로고
    • An objective case definition of lipodystrophy in HIV-infected adults: A case-control study
    • Carr A, Emery S, Law M, et al. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003;361:726-35.
    • (2003) Lancet , vol.361 , pp. 726-735
    • Carr, A.1    Emery, S.2    Law, M.3
  • 15
    • 0032493043 scopus 로고    scopus 로고
    • A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
    • Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8.
    • (1998) AIDS , vol.12
    • Carr, A.1    Samaras, K.2    Burton, S.3
  • 16
    • 0033583977 scopus 로고    scopus 로고
    • Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
    • Carr A, Samaras K, Thorisdottir A, et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093-9.
    • (1999) Lancet , vol.353 , pp. 2093-2099
    • Carr, A.1    Samaras, K.2    Thorisdottir, A.3
  • 17
    • 4444276506 scopus 로고    scopus 로고
    • Cardio- and cerebrovascular events in HIV-infected persons
    • D'Arminio A, Sabin CA, Phillips AN, et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 2004;18:1811-7.
    • (2004) AIDS , vol.18 , pp. 1811-1817
    • D'Arminio, A.1    Sabin, C.A.2    Phillips, A.N.3
  • 18
    • 12144287338 scopus 로고    scopus 로고
    • Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients
    • Driscoll SD, Meininger GE, Lareau MT, et al. Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients. AIDS 2004;18:465-73.
    • (2004) AIDS , vol.18 , pp. 465-473
    • Driscoll, S.D.1    Meininger, G.E.2    Lareau, M.T.3
  • 19
    • 2442566522 scopus 로고    scopus 로고
    • Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients
    • Driscoll SD, Meininger GE, Ljungquist K, et al. Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 2004;89:2171-8.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 2171-2178
    • Driscoll, S.D.1    Meininger, G.E.2    Ljungquist, K.3
  • 20
    • 0042832397 scopus 로고    scopus 로고
    • Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
    • Dube MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis 2003;37:613-27.
    • (2003) Clin Infect Dis , vol.37 , pp. 613-627
    • Dube, M.P.1    Stein, J.H.2    Aberg, J.A.3
  • 21
    • 0345064200 scopus 로고    scopus 로고
    • Combination antiretroviral therapy and the risk of myocardial infarction
    • Friis-Moller N, Sabin CA, et al., for the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
    • (2003) N Engl J Med , vol.349 , pp. 1993-2003
    • Friis-Moller, N.1    Sabin, C.A.2
  • 22
    • 0036828824 scopus 로고    scopus 로고
    • Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy
    • Gan SK, Samaras K, Thompson CH, et al. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes 2002;51:3163-9.
    • (2002) Diabetes , vol.51 , pp. 3163-3169
    • Gan, S.K.1    Samaras, K.2    Thompson, C.H.3
  • 23
    • 0042769119 scopus 로고    scopus 로고
    • Hypertension among HIV patients: Prevalence and relationships to insulin resistance and metabolic syndrome
    • Gazzaruso C, Bruno R, Garzaniti A, et al. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens 2003;21:1377-82.
    • (2003) J Hypertens , vol.21 , pp. 1377-1382
    • Gazzaruso, C.1    Bruno, R.2    Garzaniti, A.3
  • 24
    • 3943052088 scopus 로고    scopus 로고
    • Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy
    • Gerber MT, Mondy KE, Yarasheski KE, et al. Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy. Clin Infect Dis 2004;39:419-25.
    • (2004) Clin Infect Dis , vol.39 , pp. 419-425
    • Gerber, M.T.1    Mondy, K.E.2    Yarasheski, K.E.3
  • 25
    • 11344293751 scopus 로고    scopus 로고
    • Cardiovascular risk and body-fat abnormalites in HIV-infected patients
    • Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalites in HIV-infected patients. N Engl J Med 2005;352:48-62.
    • (2005) N Engl J Med , vol.352 , pp. 48-62
    • Grinspoon, S.1    Carr, A.2
  • 26
    • 0035092690 scopus 로고    scopus 로고
    • Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance
    • Hadigan C, Meigs JB, Rabe J, et al. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab 2001;86:939-43.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 939-943
    • Hadigan, C.1    Meigs, J.B.2    Rabe, J.3
  • 27
    • 1642580535 scopus 로고    scopus 로고
    • Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection
    • Hsue PY, Giri K, Erickson S, et al. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation 2004;109:316-9.
    • (2004) Circulation , vol.109 , pp. 316-319
    • Hsue, P.Y.1    Giri, K.2    Erickson, S.3
  • 28
    • 0035288396 scopus 로고    scopus 로고
    • Antiretroviral therapy and the lipodystrophy syndrome
    • John M, Nolan D, Mallal S. Antiretroviral therapy and the lipodystrophy syndrome. Antiviral Ther 2001;6:9-20.
    • (2001) Antiviral Ther , vol.6 , pp. 9-20
    • John, M.1    Nolan, D.2    Mallal, S.3
  • 29
    • 0042732970 scopus 로고    scopus 로고
    • Expression of adipogenic transcription factors. Peroxisome proliferator-activated receptor gamma co-activator, IL-6, and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy
    • Kannisto K, Sutinen J, Korsheninnikova E, et al. Expression of adipogenic transcription factors. Peroxisome proliferator-activated receptor gamma co-activator, IL-6, and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy. AIDS 2003;17:1753-62.
    • (2003) AIDS , vol.17 , pp. 1753-1762
    • Kannisto, K.1    Sutinen, J.2    Korsheninnikova, E.3
  • 30
    • 0036236967 scopus 로고    scopus 로고
    • Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy
    • Koppel K, Bratt G, Schulman S, et al. Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002;29:441-9.
    • (2002) J Acquir Immune Defic Syndr , vol.29 , pp. 441-449
    • Koppel, K.1    Bratt, G.2    Schulman, S.3
  • 31
    • 0037677691 scopus 로고    scopus 로고
    • HIV protease inhibitors acutely impair glucose-stimulated insulin release
    • Koster JC, Remedi MS, Qiu H, et al. HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes 2003;52:1695-700.
    • (2003) Diabetes , vol.52 , pp. 1695-1700
    • Koster, J.C.1    Remedi, M.S.2    Qiu, H.3
  • 32
    • 25444445951 scopus 로고    scopus 로고
    • Recombinant human growth hormone enhances patient-reported body image and improves quality of life in HIV-associated adipose redistribution
    • Kotler DP, Turner R, Su M, et al. Recombinant human growth hormone enhances patient-reported body image and improves quality of life in HIV-associated adipose redistribution. Antiviral Ther 2003;8:L59.
    • (2003) Antiviral Ther , vol.8
    • Kotler, D.P.1    Turner, R.2    Su, M.3
  • 33
    • 0035661381 scopus 로고    scopus 로고
    • HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlpidemia
    • Liang JS, Distler O, Cooper DA, et al. HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlpidemia. Nat Med 2001;7:1327-31.
    • (2001) Nat Med , vol.7 , pp. 1327-1331
    • Liang, J.S.1    Distler, O.2    Cooper, D.A.3
  • 34
    • 3242747137 scopus 로고    scopus 로고
    • Increased expression of TNFα, IL-6, and IL-8 in HIV-associated lipodystrophy. Implications for the reduced expression and plasma levels of adiponectin
    • Lihn AS, Richelsen B, Pedersen SB, et al. Increased expression of TNFα, IL-6, and IL-8 in HIV-associated lipodystrophy. Implications for the reduced expression and plasma levels of adiponectin. Am J Physiol Endocrinol Metab 2004;86:E8-13.
    • (2004) Am J Physiol Endocrinol Metab , vol.86
    • Lihn, A.S.1    Richelsen, B.2    Pedersen, S.B.3
  • 35
    • 0033924871 scopus 로고    scopus 로고
    • Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
    • Mallal SA, John M, Moore CB, et al. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 2000;14:1309-16.
    • (2000) AIDS , vol.14 , pp. 1309-1316
    • Mallal, S.A.1    John, M.2    Moore, C.B.3
  • 36
    • 0038708272 scopus 로고    scopus 로고
    • Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
    • Mallon PWG, Miller J, Cooper DA, et al. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS 2003;17:971-9.
    • (2003) AIDS , vol.17 , pp. 971-979
    • Mallon, P.W.G.1    Miller, J.2    Cooper, D.A.3
  • 37
    • 1642403331 scopus 로고    scopus 로고
    • Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men
    • Mary-Krause M, Cotte L, Simon A, et al. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003;17:2479-86.
    • (2003) AIDS , vol.17 , pp. 2479-2486
    • Mary-Krause, M.1    Cotte, L.2    Simon, A.3
  • 38
    • 0036182863 scopus 로고    scopus 로고
    • Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution
    • Meininger G, Hadigan C, Laposata M, et al. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution. Metabolism 2002;51:260-6.
    • (2002) Metabolism , vol.51 , pp. 260-266
    • Meininger, G.1    Hadigan, C.2    Laposata, M.3
  • 39
    • 0037045056 scopus 로고    scopus 로고
    • A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia
    • Miller J, Brown D, Amin J, et al. A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia. AIDS 2002;16:2195-200.
    • (2002) AIDS , vol.16 , pp. 2195-2200
    • Miller, J.1    Brown, D.2    Amin, J.3
  • 40
    • 21144450815 scopus 로고    scopus 로고
    • Switching to atazanavir improves metabolic disorders in patients with severe hyperlipidemia
    • Möbius U, Lubach-Ruitman M, Castro-Frenzel B, et al. Switching to atazanavir improves metabolic disorders in patients with severe hyperlipidemia. J Acquir Immune Defic Syndr 2005;39:174-80.
    • (2005) J Acquir Immune Defic Syndr , vol.39 , pp. 174-180
    • Möbius, U.1    Lubach-Ruitman, M.2    Castro-Frenzel, B.3
  • 41
    • 0037066357 scopus 로고    scopus 로고
    • Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations
    • Murata H, Hruz PW, Mueckler M. Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations. AIDS 2002;16:859-63.
    • (2002) AIDS , vol.16 , pp. 859-863
    • Murata, H.1    Hruz, P.W.2    Mueckler, M.3
  • 42
    • 0035666441 scopus 로고    scopus 로고
    • Antiretoviral therapy and the lipodystrophy syndrome, part 2: Concepts in aetiopathogenesis
    • Nolan D, John M, Mallal S. Antiretoviral therapy and the lipodystrophy syndrome, part 2: Concepts in aetiopathogenesis. Antiviral Ther 2001;6:145-60.
    • (2001) Antiviral Ther , vol.6 , pp. 145-160
    • Nolan, D.1    John, M.2    Mallal, S.3
  • 43
    • 0035805218 scopus 로고    scopus 로고
    • Metabolic effects of indinavir in healthy HIV-seronegative men
    • Noor MA, Lo JC, Mulligan K, et al. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS 2001;15:F11-8.
    • (2001) AIDS , vol.15
    • Noor, M.A.1    Lo, J.C.2    Mulligan, K.3
  • 44
    • 0037192590 scopus 로고    scopus 로고
    • Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled study
    • Noor MA, Seneviratne T, Aweeka FT, et al. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS 2002;16:F1-8.
    • (2002) AIDS , vol.16
    • Noor, M.A.1    Seneviratne, T.2    Aweeka, F.T.3
  • 45
    • 0033963686 scopus 로고    scopus 로고
    • Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects
    • Purnell JQ, Zambon A, Knopp RH, et al. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS 2000;14:51-7.
    • (2000) AIDS , vol.14 , pp. 51-57
    • Purnell, J.Q.1    Zambon, A.2    Knopp, R.H.3
  • 46
    • 2942655667 scopus 로고    scopus 로고
    • Fenofibrate is effective in treating hypertriglyceridemia associated with HIV lipodystrophy
    • Rao A, D'Amico S, Balasubramanyam A, et al. Fenofibrate is effective in treating hypertriglyceridemia associated with HIV lipodystrophy. Am J Med Sci 2004;327:315-8.
    • (2004) Am J Med Sci , vol.327 , pp. 315-318
    • Rao, A.1    D'Amico, S.2    Balasubramanyam, A.3
  • 47
    • 0012570692 scopus 로고    scopus 로고
    • Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study
    • Saint-Marc T, Partisani M, Poizot-Martin I, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 2000;14:37-49.
    • (2000) AIDS , vol.14 , pp. 37-49
    • Saint-Marc, T.1    Partisani, M.2    Poizot-Martin, I.3
  • 48
    • 0035914028 scopus 로고    scopus 로고
    • Elevated blood pressure in subjects with lipodystrophy
    • Sattler FR, Qian D, Louie S, et al. Elevated blood pressure in subjects with lipodystrophy. AIDS 2001;15:2001-10.
    • (2001) AIDS , vol.15 , pp. 2001-2010
    • Sattler, F.R.1    Qian, D.2    Louie, S.3
  • 49
    • 0036840147 scopus 로고    scopus 로고
    • Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS-Society-USA panel
    • Schambelan M, Benson CA, Carr A, et al. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS-Society-USA panel. J Acquir Immune Defic Syndr 2002;31:257-75.
    • (2002) J Acquir Immune Defic Syndr , vol.31 , pp. 257-275
    • Schambelan, M.1    Benson, C.A.2    Carr, A.3
  • 50
    • 20644450805 scopus 로고    scopus 로고
    • Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003
    • Seaberg EC, Munoz A, Lu M, et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005;19:953-60.
    • (2005) AIDS , vol.19 , pp. 953-960
    • Seaberg, E.C.1    Munoz, A.2    Lu, M.3
  • 52
    • 3142546243 scopus 로고    scopus 로고
    • Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors
    • Stein JH, Merwood MA, Bellehumeur JL, et al. Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors. Am Heart J 2004;147:E18.
    • (2004) Am Heart J , vol.147
    • Stein, J.H.1    Merwood, M.A.2    Bellehumeur, J.L.3
  • 53
    • 0043157304 scopus 로고    scopus 로고
    • Rosiglitazone in the treatment of HAART-associated lipodystrophy - A randomized double-blinded placebo controlled study
    • Sutinen J, Hakkinen AM, Westerbacka J, et al. Rosiglitazone in the treatment of HAART-associated lipodystrophy - a randomized double-blinded placebo controlled study. Antiviral Ther 2003;8:199-207.
    • (2003) Antiviral Ther , vol.8 , pp. 199-207
    • Sutinen, J.1    Hakkinen, A.M.2    Westerbacka, J.3
  • 54
    • 0035834508 scopus 로고    scopus 로고
    • Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways
    • Van der Valk M, Bisschop PH, Romijn JA, et al. Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS 2001;15:2093-100.
    • (2001) AIDS , vol.15 , pp. 2093-2100
    • Van Der Valk, M.1    Bisschop, P.H.2    Romijn, J.A.3
  • 55
    • 0032558803 scopus 로고    scopus 로고
    • Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
    • Walli R, Herfort O, Michl GM, et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 1998;12:167-73.
    • (1998) AIDS , vol.12 , pp. 167-173
    • Walli, R.1    Herfort, O.2    Michl, G.M.3
  • 56
    • 0037390373 scopus 로고    scopus 로고
    • Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy
    • Yki-Jarvinen H, Sutinen J, Silveira A, et al. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arterioscler Thromb Vasc Biol 2003;23:688-94.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 688-694
    • Yki-Jarvinen, H.1    Sutinen, J.2    Silveira, A.3
  • 57
    • 4744363012 scopus 로고    scopus 로고
    • Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy
    • Young EM, Considine RV, Sattler FR, et al. Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy. Cardiovasc Toxicol 2004;4:179-86.
    • (2004) Cardiovasc Toxicol , vol.4 , pp. 179-186
    • Young, E.M.1    Considine, R.V.2    Sattler, F.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.